October 18-20 | Tucson, AZ

The Research Institution GAP Fund and Accelerator Program Summit

Visit Event Site

Ocular therapeutics start-up wins University College Dublin VentureLaunch Award 

GET GAP Insights

Join Us

October 16-17, 2025 / Seattle, WA

The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds

Visit event site

The Story

OcuHealth, an emerging eye therapeutics start-up, was named overall winner of University College Dublin’s (UCD) VentureLaunch Accelerator Programme for 2025. The joint UCD and South East Technological University (SETU) project received €700,000 through the Enterprise Ireland Commercialisation Fund and is already being supported by technology transfer offices at SETU and NovaUCD.

The company is developing novel formulations to treat eye disease in the form of a daily eyedrop that can deliver conventional small molecules and large biomolecules, in a slow and sustained manner, to all parts of the eye, substantially improving on current treatment options.

While OcuHealth’s platform technology could be used to treat many different eye diseases, its initial target is dry eye disease, a common condition involving pain, inflammation and irritation at the surface of the eye.

 

Full story: Ocular therapeutics start-up wins VentureLaunch Award – TechCentral.ie

JOIN THE COMMUNITY

Get the Report

More GAP News

Consortium For Gap Fund and Accelerator ProgramS

Explore Institutional Participation

The Consortium provides a dedicated, institutional coordinating forum for collective insight, program refinement, and structured engagement with aligned commercial, investment, and philanthropic partners.

GAP are an interdependent institutional innovation and capital strategy that includes:

  • Translational research

  • Proof of concept programs

  • Startup accelerators

  • University venture funds

Get GAP Insights